Search for: "BOEHRINGER INGELHEIM PHARMA GMBH " Results 21 - 33 of 33
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Dec 2009, 3:44 am by gmlevine
In this event Panels partially dismiss complaints to the extent that they include additional unrelated respondents, as in Boehringer Ingelheim Pharma GmbH & Co. [read post]
25 Aug 2009, 1:30 pm
Boehringer Ingelheim International GmbH v Commissioner of Patents [2001] FCA 647 and Prejay Holdings Ltd v Commissioner of Patents [2003] FCAFC 77 applied. [read post]
9 Aug 2009, 4:54 pm
Boehringer Ingelheim Pharma GmbH & Co. [read post]
6 Feb 2009, 5:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Jan 2009, 3:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Dec 2008, 2:35 pm
In Austria Paranova marketed genuine pharma products bearing the mark ZOVIRAX in packs of 60 x 400 mg tablets (ZOVIRAX 400/60), which were legitimately put on the market in the countries of the European Economic Area and which Paranova's parent company bought in the normal course of trade. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
11 Jul 2008, 4:30 am
: (Spicy IP), India: Ranbaxy-Daiichi deal – Opportunities for private equity companies in India: (Profitability through Simplicity), India: (KEI) Cracking open anti-competitive practices in the developing world: complaints, amendments and waivers: (Spicy IP), India: Is it one rule for Indian pharma companies and another one for those from abroad? [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market:… [read post]
15 Jul 2007, 6:11 pm
Boehringer Ingelheim Pharma GmbH Co. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]